WHO Prequalifies First Ever Malaria Treatment for Newborns and Infants – Asrar Qureshi’s Blog Post #1259

The WHO’s approval of Coartem Baby marks a historic achievement in malaria treatment for newborns and young infants, addressing a critical gap in healthcare. Developed by Novartis and Medicines for Malaria Venture, this innovative drug provides a safer, accurately dosed option, highlighting the importance of inclusive pharmaceutical innovation and collaborative efforts in global health.
Share
View Post

Balancing Execution and Innovation in a Fast-Changing World – Asrar Qureshi’s Blog Post 1156

This blog post addresses senior managers in the pharmaceutical industry, emphasizing the critical balance between execution and innovation. It highlights the risks of focusing solely on one, urging leaders to foster environments that nurture both disciplines. The dual operating system model by John P. Kotter is presented as a solution for sustainable growth amidst constant change.
Share
View Post

Technical Expertise vs Customer Experience – Asrar Qureshi’s Blog Post 1150

Asrar Qureshi’s blog post discusses the importance of balancing technical innovation with customer experience in the pharmaceutical industry. Historical examples like Exubera and Vioxx illustrate how neglecting user needs can lead to commercial failure. The future of pharma hinges on prioritizing usability, safety, trust, and accessibility to ensure successful adoption.
Share
View Post

Putting Patient Care First – Asrar Qureshi’s Blog Post #1120

In healthcare, patient care must be prioritized above profit-driven motives, as emphasized by Drew Ungerman from McKinsey. Effective systems should focus on improving patient experiences, shifting from “sick care” to “health care.” Innovations should enhance access and reduce disparities, ensuring care is human-centered, dignified, and empathetic.
Share
View Post

Five AI Trends to Watch in 2025 (and Beyond) – Asrar Qureshi’s Blog Post #1061

Asrar Qureshi’s blog outlines five significant AI trends expected by 2025. These include the democratization of coding through AI tools, the creation of high-quality AI-generated films, the rise of autonomous AI agents, improving affordability and performance of AI technologies, and an ongoing AI development surge amidst limited government regulation.
Share